Development of Prodrugs for Enzyme-Mediated, Tumor-Selective Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
5
Page:
107-113
Author(s):
K. Jin Yoon, Philip M. Potter and Mary K. Danks
Anti-Angiogenic Therapy as a Cancer Treatment Paradigm
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
5
Page:
115-130
Author(s):
Mohanraj Dhanabal, Mike Jeffers and William J. LaRochelle
Activation of p53 by Specific Agents in Potential Cancer Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
5
Page:
131-135
Author(s):
John W. Ho, Jing Zheng Song and Yuet Kin Leung
Metal Complexes with Aromatic N-Containing Ligands as Potential Agents in Cancer Treatment
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
5
Page:
137-147
Author(s):
Guanghua Zhao and Huakuan Lin
Cytotoxic and Antitumor Potentialities of Aporphinoid Alkaloids
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
5
Page:
173-182
Author(s):
C. Stevigny, C. Bailly and J. Quetin-Leclercq
Retroviral Gene Therapy: Safety Issues and Possible Solutions
Journal:
Current Gene Therapy
Volume:
5
Page:
25-35
Author(s):
Youngsuk Yi, Sung Ho Hahm and Kwan Hee Lee
Gene Therapy in Plastic and Reconstructive Surgery
Journal:
Current Gene Therapy
Volume:
5
Page:
81-99
Author(s):
S. Roman, R. Lindeman, G. O'Toole and M. D. Poole
Clinical Applications of Cardiovascular Magnetic Resonance
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
457-475
Author(s):
Norbert Watzinger, Robert Maier, Ursula Reiter, Gert Reiter, Georg Fuernau, Manfred Wonisch, Friedrich M Fruhwald, Martin Schumacher, Robert Zweiker, Rainer Rienmueller and Werner Klein1
p53-Independent Activities of MDM2 and Their Relevance to Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
9-20
Author(s):
Zhuo Zhang and Ruiwen Zhang
MDM2 Splice Variants and Their Therapeutic Implications
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
21-26
Author(s):
L. C. Harris